ClinVar Miner

Submissions for variant NM_000503.6(EYA1):c.806del (p.Ala269fs)

dbSNP: rs1819903817
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001061934 SCV001226698 pathogenic Melnick-Fraser syndrome 2019-04-06 criteria provided, single submitter clinical testing Loss-of-function variants in EYA1 are known to be pathogenic (PMID: 18220287, 10464653). This sequence change creates a premature translational stop signal (p.Ala269Glufs*97) in the EYA1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in several individuals affected with brachio-oto-renal syndrome (PMID: 18220287, 15146463). This variant is also known as NM_172060.1:c.707delC (p.M332X) in the literature. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.